Explore Our Latest News

Stay Up to Date on the Breakthroughs and Events Shaping the Future of Radiopharmaceuticals

Upcoming Events

May 30 – June 2, 2026 | Los Angeles, CA

SNMMI Annual Meeting

July 21 – 23, 2026 | La Jolla, CA

Targeted Radiopharmaceuticals Summit USA

October 17 – 21, 2026 | Vienna, Austria

EANM Annual Meeting

Press Releases

July 11, 2023

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

Read

June 21, 2023

UPMC and PharmaLogic Partner to Develop Novel Radiopharmaceuticals at New Facility in Pittsburgh

Read

June 13, 2023

PharmaLogic and Evergreen Theragnostics Announce Partnership for Sales and Distribution of OCTEVY™ (Kit for Preparation of Ga 68 DOTATOC Injection), pending FDA approval in 2H 2023

Read

May 15, 2023

NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumours

Read

May 15, 2023

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

Read

March 14, 2023

Perspective Therapeutics and PharmaLogic announce collaboration for the development and production of theranostics for cancer care

Read